![Nicholas Maestas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Maestas
Directeur Financier/CFO chez
RANI THERAPEUTICS HOLDINGS, INC.
Fortune : 655 $ au 30/06/2026
Profil
Nicholas Maestas is currently Chief Financial & Accounting Officer at Rani Therapeutics Holdings, Inc. since 2026.
Formerly, Mr. Maestas was Chief Financial Officer, Secretary & Head-Strategy at Tempest Therapeutics, Inc. from 2025 to 2026, Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021, and Senior Director-Corporate Development & Operations at Immune Design Corp.
in 2019.
Mr. Maestas completed undergraduate education at the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 590 ( 0 % ) | 655 $ | 30/06/2026 |
Postes actifs de Nicholas Maestas
| Sociétés | Poste | Début |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Directeur Financier/CFO | 29/06/2026 |
Anciens postes connus de Nicholas Maestas
| Sociétés | Poste | Fin |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Directeur Financier/CFO | 05/06/2026 |
| ALECTOR, INC. | Corporate Officer/Principal | 01/07/2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01/07/2019 |
Formation de Nicholas Maestas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
